Aarey Drugs & Pharmaceuticals Limited
NSE: AAREYDRUGS
NSE
58.62
-0.20 (-0.34%)
Prev Close
58.82
Open Price
58.03
Volume
35,691
Today Low / High
57.07 / 60
52 WK Low / High
32.85 / 74.8
Range
56 - 62
Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 58.62, with a change of -0.2 (-0.34002%). The expected target range on the NSE is between 56 - 62. The stock is experiencing a downward trend on the NSE. Investors should be cautious as the price is currently declining.
24 Apr
58.03
1.02%
23 Apr
58.01
1.40%
22 Apr
57.98
-0.12%
21 Apr
57.77
-0.68%
17 Apr
57.99
-3.33%
16 Apr
55.05
0.33%
15 Apr
50.70
3.75%
11 Apr
47.44
6.07%
09 Apr
47.50
1.12%
08 Apr
46.98
0.17%
07 Apr
45.28
0.00%
04 Apr
48.00
-0.69%
03 Apr
44.59
0.00%
02 Apr
38.01
6.66%
01 Apr
33.89
8.76%
28 Mar
36.00
-6.92%
27 Mar
36.45
0.14%
Aarey Drugs & Pharmaceuticals Limited Graph
Aarey Drugs & Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Aarey Drugs & Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 58.62, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 58.62 | 59.21 | 53.29 - 65.13 |
| 59.79 | 47.83 - 71.75 | ||
| 60.38 | 42.27 - 78.49 | ||
| Bearish Scenario | 58.62 | 58.03 | 52.23 - 63.84 |
| 57.45 | 45.96 - 68.94 | ||
| 56.86 | 39.80 - 73.92 |
Overview of Aarey Drugs & Pharmaceuticals Limited
ISIN
INE198H01019
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
43,900
Market Cap
1,662,129,066
Last Dividend
0
Official Website
IPO Date
2021-08-06
DCF Diff
81.80
DCF
-23
Financial Ratios Every Investor Needs
Stock Dividend of AAREYDRUGS
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2018-12-13 | December 13, 18 | 0.1 | 0.1 | 2018-12-14 | 2018-12-30 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 395.10 Cr | 381.90 Cr | 13.20 Cr | 0.0334 | 0.00 Cr | 0.42 Cr | 2.82 Cr | 4.68 Cr | 1.84 | 11.42 Cr | 0.0119 |
| 2023-03-31 | 414.25 Cr | 403.84 Cr | 10.41 Cr | 0.0251 | 0.00 Cr | 0.88 Cr | 6.69 Cr | 3.77 Cr | 1.49 | 8.27 Cr | 0.0091 |
| 2022-03-31 | 491.61 Cr | 472.06 Cr | 19.54 Cr | 0.0398 | 0.00 Cr | 0.61 Cr | 10.03 Cr | 6.55 Cr | 2.72 | 12.01 Cr | 0.0133 |
| 2021-03-31 | 347.89 Cr | 337.79 Cr | 10.10 Cr | 0.0290 | 0.00 Cr | 0.32 Cr | 8.23 Cr | 6.51 Cr | 2.79 | 9.15 Cr | 0.0187 |
| 2020-03-31 | 300.09 Cr | 290.18 Cr | 9.91 Cr | 0.0330 | 0.00 Cr | 0.43 Cr | 6.35 Cr | 5.79 Cr | 2.48 | 7.25 Cr | 0.0193 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 1.59 Cr | 303.29 Cr | 170.52 Cr | 132.7734 Cr | 31.35 Cr | 29.76 Cr | 71.99 Cr | 12.96 Cr | 0.00 Cr | 0.00 Cr | 2.09 Cr | 166.5469 Cr |
| 2023-03-31 | 0.71 Cr | 291.32 Cr | 173.91 Cr | 117.4138 Cr | 37.72 Cr | 37.01 Cr | 28.82 Cr | 13.94 Cr | 5.28 Cr | 0.00 Cr | 0.41 Cr | 168.1349 Cr |
| 2022-03-31 | 0.19 Cr | 245.17 Cr | 131.53 Cr | 113.6373 Cr | 14.16 Cr | 13.97 Cr | 13.68 Cr | 14.47 Cr | 5.23 Cr | -3.34 Cr | 2.80 Cr | 130.0762 Cr |
| 2021-03-31 | 0.64 Cr | 233.04 Cr | 134.18 Cr | 98.8605 Cr | 18.02 Cr | 17.38 Cr | 18.46 Cr | 14.26 Cr | 4.25 Cr | 0.00 Cr | 0.40 Cr | 132.6120 Cr |
| 2020-03-31 | 0.49 Cr | 194.08 Cr | 101.74 Cr | 92.3462 Cr | 17.89 Cr | 17.40 Cr | 17.00 Cr | 12.34 Cr | 4.64 Cr | 0.00 Cr | 0.40 Cr | 100.2778 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | -2.9938 Cr | -1.7023 Cr | 5.5848 Cr | -3.7161 Cr | 0.8886 Cr | 1.5944 Cr | -0.7223 Cr | 4.6837 Cr | -1.1362 Cr | 0.0000 Cr | -5.8566 Cr |
| 2023-03-31 | -1.2811 Cr | 0.4410 Cr | 1.3540 Cr | -2.3251 Cr | 0.5139 Cr | 0.7058 Cr | -1.0440 Cr | 6.0151 Cr | 4.2211 Cr | 0.0000 Cr | -15.1352 Cr |
| 2022-03-31 | -4.4930 Cr | -2.1967 Cr | 6.2319 Cr | -6.6943 Cr | -0.4578 Cr | 0.1919 Cr | -2.2013 Cr | 10.0271 Cr | 0.0000 Cr | 0.0000 Cr | 4.7767 Cr |
| 2021-03-31 | 5.4770 Cr | -2.8793 Cr | -2.4507 Cr | 2.5977 Cr | 0.1470 Cr | 0.6497 Cr | -2.8793 Cr | 8.3014 Cr | -0.0191 Cr | 0.0000 Cr | -1.4646 Cr |
| 2020-03-31 | 2.8572 Cr | -0.9186 Cr | -1.8047 Cr | 1.9386 Cr | 0.1340 Cr | 0.5027 Cr | -0.9186 Cr | 7.2424 Cr | -0.0195 Cr | 0.0000 Cr | 4.2543 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 133.79 Cr | 130.39 Cr | 3.40 Cr | 0.0254 | 1.62 Cr | 0.72 Cr | 0.26 | 2.88 Cr | 0.0054 |
| 2024-09-30 | 105.14 Cr | 98.90 Cr | 6.24 Cr | 0.0594 | 3.23 Cr | 1.60 Cr | 0.57 | 3.74 Cr | 0.0152 |
| 2024-06-30 | 126.91 Cr | 123.59 Cr | 3.32 Cr | 0.0261 | 2.58 Cr | 1.24 Cr | 0.44 | 2.75 Cr | 0.0098 |
| 2024-03-31 | 210.35 Cr | 206.75 Cr | 3.60 Cr | 0.0171 | -1.84 Cr | 2.15 Cr | 0.77 | 3.70 Cr | 0.0102 |
| 2023-12-31 | 76.48 Cr | 73.34 Cr | 3.14 Cr | 0.0410 | 2.23 Cr | 1.91 Cr | 0.75 | 3.00 Cr | 0.0249 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 1.49 Cr | 0.00 Cr | 1.49 Cr | 0.00 Cr | 29.84 Cr | 251.35 Cr | 12.99 Cr | 274.53 Cr | 138.94 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 2.89 Cr | 0.00 Cr | 0.00 Cr | 2.89 Cr | 0.00 Cr | 0.00 Cr | -132.77 Cr |
| 2024-03-31 | 1.59 Cr | 1.30 Cr | 1.59 Cr | 200.85 Cr | 34.68 Cr | 282.60 Cr | 14.66 Cr | 304.99 Cr | 172.22 Cr |
| 2023-12-31 | -7.46 Cr | 14.91 Cr | 7.46 Cr | 0.00 Cr | 0.00 Cr | 7.46 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 1.17 Cr | 6.29 Cr | 7.46 Cr | 109.54 Cr | 22.37 Cr | 217.98 Cr | 13.23 Cr | 233.99 Cr | 115.07 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 1.24 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 2.15 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 1.02 Cr | 0.94 Cr | 0.00 Cr | 0.00 Cr | 0.94 Cr | 2.11 Cr | 1.17 Cr | 0.00 Cr | 0.94 Cr |
| 2023-09-30 | 0.78 Cr | 0.82 Cr | 0.00 Cr | 0.00 Cr | 0.82 Cr | 1.17 Cr | 0.35 Cr | 0.00 Cr | 0.82 Cr |
| 2023-06-30 | 0.72 Cr | 0.83 Cr | 0.00 Cr | 0.00 Cr | 0.83 Cr | 1.54 Cr | 0.71 Cr | 0.00 Cr | 0.83 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,803.90 | ₹4,328,061,192,000.00 | ₹2,100,537.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,215.50 | ₹1,650,019,896,835.00 | ₹2,081,003.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,325.10 | ₹1,125,363,469,500.00 | ₹233,320.00 |
| Mankind Pharma Limited | MANKIND | ₹2,599.20 | ₹1,072,374,089,184.00 | ₹377,773.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,200.50 | ₹1,000,152,180,510.00 | ₹4,818,144.00 |
| Lupin Limited | LUPIN | ₹2,104.10 | ₹960,658,479,623.00 | ₹1,580,050.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹880.25 | ₹885,733,957,500.00 | ₹1,164,194.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,257.80 | ₹730,532,755,600.00 | ₹1,338,274.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,201.20 | ₹621,881,478,000.00 | ₹138,164.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,420.90 | ₹400,960,929,200.00 | ₹1,391,085.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,445.70 | ₹366,779,872,800.00 | ₹175,209.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,790.40 | ₹348,554,444,800.00 | ₹239,346.00 |
| Laurus Labs Limited | LAURUSLABS | ₹645.50 | ₹348,087,811,500.00 | ₹7,230,008.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,204.80 | ₹306,699,912,000.00 | ₹269,079.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,609.10 | ₹250,500,214,702.00 | ₹175,168.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,465.20 | ₹238,064,230,800.00 | ₹1,148,314.00 |
| Piramal Enterprises Limited | PEL | ₹1,021.60 | ₹230,348,324,800.00 | ₹349,675.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,967.50 | ₹224,187,500,000.00 | ₹18,935.00 |
| Eris Lifesciences Limited | ERIS | ₹1,512.00 | ₹205,827,048,000.00 | ₹433,227.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹880.55 | ₹173,083,664,122.00 | ₹310,579.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,079.00 | ₹167,802,262,100.00 | ₹52,920.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹902.85 | ₹161,709,463,500.00 | ₹16,724,971.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹952.65 | ₹151,739,178,021.00 | ₹684,427.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,884.40 | ₹143,236,447,480.00 | ₹153,894.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹475.05 | ₹115,220,527,200.00 | ₹1,362,207.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,221.50 | ₹86,673,767,100.00 | ₹4,879.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹721.80 | ₹70,585,471,620.00 | ₹517,725.00 |
| FDC Limited | FDC | ₹426.15 | ₹69,381,481,500.00 | ₹253,775.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹753.90 | ₹68,329,440,018.00 | ₹548,769.00 |
| Strides Pharma Science Limited | STAR | ₹681.05 | ₹62,767,406,835.00 | ₹639,460.00 |
| Innova Captab Limited | INNOVACAP | ₹910.95 | ₹52,129,049,984.00 | ₹78,436.00 |
| Hikal Limited | HIKAL | ₹416.75 | ₹51,385,691,750.00 | ₹273,356.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹154.99 | ₹50,297,664,780.00 | ₹933,378.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹640.35 | ₹45,084,354,030.00 | ₹43,561.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹843.50 | ₹42,781,560,850.00 | ₹107,819.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,333.40 | ₹38,592,102,600.00 | ₹15,218.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹384.50 | ₹38,556,891,000.00 | ₹372,674.00 |
| Sequent Scientific Limited | SEQUENT | ₹154.04 | ₹38,556,520,080.00 | ₹1,239,540.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹62.22 | ₹34,093,697,880.00 | ₹39,557,174.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹365.85 | ₹33,391,129,500.00 | ₹235,772.00 |
| Suven Life Sciences Limited | SUVEN | ₹141.20 | ₹30,792,048,800.00 | ₹1,492,336.00 |
| Alembic Limited | ALEMBICLTD | ₹106.25 | ₹27,283,087,394.00 | ₹492,387.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹534.15 | ₹25,667,509,950.00 | ₹126,098.00 |
Key Executives
Company Secretary & Compliance Officer
Mr. Kailash Chand Jethlia
Gender: male
Year Born:
Chairman & MD
Mr. Mihir Rajesh Ghatalia B.E
Gender: male
Year Born: 1983
Chief Accountant
Mr. A. S. Kathawala
Gender: male
Year Born: 1976
Chief Financial Officer
Ms. Mira Mihir Ghatalia
Gender: female
Year Born:
Executive Director
Mr. Nimit Rajesh Ghatalia
Gender: male
Year Born: 1996
FAQs about Aarey Drugs & Pharmaceuticals Limited
Who is the CEO of the company?
The CEO is Mr. Mihir Rajesh Ghatalia B.E.
What is the current market price of the stock?
The current price is ₹58.62.
What is the 52-week price range?
The range is ₹32.85-74.8.
What is the market capitalization of the company?
The market capitalization is ₹166.21 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 28.82.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Aarey Drugs & Pharmaceuticals Limited (ISIN: INE198H01019) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹166.21 crores and an average daily volume of 43,900 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.